Search Results - "Madjar, K."
-
1
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
Published in Breast cancer research and treatment (01-09-2017)“…Background The role of different subtypes of immune cells is still a matter of debate. Methods We compared the prognostic relevance for metastasis-free…”
Get full text
Journal Article -
2
Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer
Published in Journal of cancer research and clinical oncology (01-07-2017)“…Purpose The transcription factor IRF4 regulates immunoglobulin class switch recombination as well as plasma cell differentiation. We examined the prognostic…”
Get full text
Journal Article -
3
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer
Published in PloS one (07-11-2017)“…Non-small cell lung cancer (NSCLC) represents a genomically unstable cancer type with extensive copy number aberrations. The relationship of gene copy number…”
Get full text
Journal Article -
4
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
Published in Journal of thoracic oncology (01-04-2019)“…Infiltration of T and B/plasma cells has been linked to NSCLC prognosis, but this has not been thoroughly investigated in relation to the expression of…”
Get more information
Journal Article -
5
Abstract P2-05-22: Prognostic significance of nuclear factor kappa B in node-negative breast cancer is most pronounced in luminal B breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2017)“…Abstract Background: The importance of the cellular as well as the humoral immune system is increasingly recognized in breast cancer. The transcription factor…”
Get full text
Journal Article -
6
Profiling cancer testis antigens in non-small-cell lung cancer
Published in JCI insight (07-07-2016)“…Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA…”
Get full text
Journal Article